Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsa Irving

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|December 20, 2017
Vanadium Compounds as PTP InhibitorsElsa Irving, Andrew W Stoker
Trends in Molecular Medicine|September 28, 2020
The Ubiquitin/UBL Drug Target RepertoireHugh C Osborne, Elsa Irving, Christine K Schmidt
Cancers|January 11, 2022
Preventing and Overcoming Resistance to PARP Inhibitors: A Focus on the Clinical LandscapeRosario Prados-Carvajal, Elsa Irving, Natalia Lukashchuk, et al.
Trends in Cell Biology|March 9, 2021
E2 enzymes in genome stability: pulling the strings behind the scenesHugh C Osborne, Elsa Irving, Josep V Forment, et al.
Scientific Reports|October 8, 2020
The liposomal delivery of hydrophobic oxidovanadium complexes imparts highly effective cytotoxicity and differentiating capacity in neuroblastoma tumour cellsElsa Irving, Aristides D Tagalakis, Ruhina Maeshima, et al.
Journal of Drug Targeting|January 7, 2020
Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cellsMaja Bilip, Shreya Shah, Mayuran Mathiyalakan, et al.
Cancers|January 28, 2026
An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy ResistanceElsa Irving, Alaide Morcavallo, Jekaterina Vohhodina-Tretjakova, et al.
Journal of Medicinal Chemistry|June 16, 2026
Discovery of CNS Penetrant SOS1 Inhibitors for the Treatment of KRAS-Dependent CancersSharan K Bagal, Coura R N Diène, Sandra Stefanovic-Barrett, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|December 20, 2017
Vanadium Compounds as PTP InhibitorsElsa Irving, Andrew W Stoker
Trends in Molecular Medicine|September 28, 2020
The Ubiquitin/UBL Drug Target RepertoireHugh C Osborne, Elsa Irving, Christine K Schmidt
Cancers|January 11, 2022
Preventing and Overcoming Resistance to PARP Inhibitors: A Focus on the Clinical LandscapeRosario Prados-Carvajal, Elsa Irving, Natalia Lukashchuk, et al.
Trends in Cell Biology|March 9, 2021
E2 enzymes in genome stability: pulling the strings behind the scenesHugh C Osborne, Elsa Irving, Josep V Forment, et al.
Scientific Reports|October 8, 2020
The liposomal delivery of hydrophobic oxidovanadium complexes imparts highly effective cytotoxicity and differentiating capacity in neuroblastoma tumour cellsElsa Irving, Aristides D Tagalakis, Ruhina Maeshima, et al.
Journal of Drug Targeting|January 7, 2020
Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cellsMaja Bilip, Shreya Shah, Mayuran Mathiyalakan, et al.
Cancers|January 28, 2026
An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy ResistanceElsa Irving, Alaide Morcavallo, Jekaterina Vohhodina-Tretjakova, et al.
Journal of Medicinal Chemistry|June 16, 2026
Discovery of CNS Penetrant SOS1 Inhibitors for the Treatment of KRAS-Dependent CancersSharan K Bagal, Coura R N Diène, Sandra Stefanovic-Barrett, et al.
Pageof 1